Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 3/20 | 0.59 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.51 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | MRGPRX4 | Q96LA9 | 4/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.49 |
| ▸ | ANPEP | P15144 | 1/20 | 0.49 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.49 |
| ▸ | MMP3 | P08254 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29471974 | 1.00 | FOLH1 (0.59) | FOLH1ENPP2NR4A2KMT2AMRGPRX4 | |
| SCHEMBL6158425 | 0.86 | L3MBTL1 (0.57) | FOLH1ENPP2KMT2AFFAR1MMP3 | |
| SCHEMBL11459736 | 0.84 | ENPP2 (0.50) | FOLH1ENPP2KMT2AMRGPRX4FFAR1 | |
| SCHEMBL9004062 | 0.84 | MAOB (0.51) | ENPP2MRGPRX4FFAR1MMP3 | |
| SCHEMBL2857119 | 0.84 | ENPP2 (0.50) | FOLH1ENPP2FFAR1MMP3 | |
| SCHEMBL7282885 | 0.83 | FOLH1 (0.61) | FOLH1NR4A2KMT2AMRGPRX4CYP2D6 | |
| SCHEMBL2857678 | 0.82 | MEN1 (0.63) | FOLH1NR4A2KMT2AMRGPRX4CYP2D6 | |
| SCHEMBL3641528 | 0.82 | MMP3 (0.67) | NR4A2MMP3 | |
| SCHEMBL31044565 | 0.81 | FOLH1 (0.59) | FOLH1NR4A2KMT2AMRGPRX4CYP2D6 | |
| SCHEMBL8463786 | 0.81 | FOLH1 (0.59) | FOLH1NR4A2KMT2AMRGPRX4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116143656-A | Preparation method of m-cyano methyl benzoate | 湖北仙盛科技股份有限公司 | 2023-05-23 | — | — | CN | claimed |
| CN-116037038-A | Reaction kettle for preparing m-cyanomethyl benzoate | 安庆市鑫琪精细化工有限公司 | 2023-05-02 | — | — | CN | claimed |
| CN-112707831-A | Synthetic method of 3- (1-aminocyclopropyl) methyl benzoate | 阿里生物新材料（常州）有限公司 | 2021-04-27 | — | — | CN | claimed |
| US-20250346616-A1 | ROCK INHIBITORS AND USES THEREOF | DIZAL JIANGSU PHARMACEUTICAL CO LTD (CN) | 2025-11-13 | — | — | US | disclosed |
| CN-117736210-A | Aromatic heterocyclic compound, and preparation method and application thereof | 上海翊石医药科技有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-114805341-B | Aromatic heterocyclic compound, and preparation method and application thereof | 上海翊石医药科技有限公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-116143656-A | Preparation method of m-cyano methyl benzoate | 湖北仙盛科技股份有限公司 | 2023-05-23 | — | — | CN | disclosed |
| CN-116037038-A | Reaction kettle for preparing m-cyanomethyl benzoate | 安庆市鑫琪精细化工有限公司 | 2023-05-02 | — | — | CN | disclosed |
| CN-116037038-A | Reaction kettle for preparing m-cyanomethyl benzoate | 安庆市鑫琪精细化工有限公司 | 2023-05-02 | — | — | CN | disclosed |
| CN-116037038-A | Reaction kettle for preparing m-cyanomethyl benzoate | 安庆市鑫琪精细化工有限公司 | 2023-05-02 | — | — | CN | disclosed |
| CN-111601807-B | Exo-azaspiro inhibitors of MENIN-MLL interactions | 詹森药业有限公司 | 2023-03-31 | — | — | CN | disclosed |
| WO-2004009546-A1 | INDOLINE DERIVATIVES SUBSTITUTED IN POSITION 6, PRODUCTION AND USE THEREOF AS MEDICAMENTS | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2004-01-29 | — | — | WO | disclosed |
| WO-2004009547-A1 | INDOLINE DERIVATIVES SUBSTITUTED IN POSITION 6, PRODUCTION AND USE THEREOF AS MEDICAMENTS | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2004-01-29 | — | — | WO | disclosed |
| US-4814346-A | Benzopyrans and use thereof in treating vascular diseases | ZYMA SA (CH) | 1989-03-21 | — | — | US | disclosed |
| EP-0107693-B1 | 2,3,4-TRINOR-1,5-INTER-M-PHENYLENE-PROSTACYCLIN-I2 ANALOGUES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. (HU) | 1988-07-27 | — | — | EP | disclosed |
| EP-0267155-A2 | Bicyclic compounds | Zyma SA (CH) | 1988-05-11 | — | — | EP | disclosed |
| US-4638002-A | ANTIAGGLOMERANTS, HYPOTENSIVE, ANTISECRETORY, ANTISPASMODIC, ANTIULCER, BRONCHODILATOR, ANTIHISTAMINES | CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) | 1987-01-20 | — | — | US | disclosed |
| EP-0107693-A4 | 2,3,4-TRINOR-1,5-INTER-M-PHENYLENE-PROSTACYCLIN-I2 ANALOGUES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME. | CHINOIN GYOGYSZER ES VEGYESZET (HU) | 1984-09-17 | — | — | EP | disclosed |
| EP-0107693-A1 | 2,3,4-TRINOR-1,5-INTER-M-PHENYLENE-PROSTACYCLIN-I2 ANALOGUES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME. | CHINOIN GYOGYSZER ES VEGYESZET (HU) | 1984-05-09 | — | — | EP | disclosed |
| WO-1983004021-A1 | 2,3,4-TRINOR-1,5-INTER-M-PHENYLENE-PROSTACYCLINE-I2 ANALOGUES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. (HU) | 1983-11-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250346616-A1 | ROCK INHIBITORS AND USES THEREOF | ROCK1, ROCK2, RHOA | FOLH1 1227/4885ENPP2 490/4885NR4A2 4790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.